Investment
Features
FeesSafety
Academy
More
Pluang+

AAR reports 24% sales growth in Q1 FY2027 and announces acquisition of MRO Holdings.

Company Fundamentals
28 Sep 2026
PRNewsWire
View Source
Bullish
AAR reports 24% sales growth in Q1 FY2027 and announces acquisition of MRO Holdings.

AAR Corp. reported a strong start to fiscal year 2027 with a 24% increase in sales to $918 million and a 38% rise in adjusted earnings per share to $1.49 for the first quarter. The company saw growth across all core segments, driven by strong demand in commercial and government markets. AAR also announced a definitive agreement to acquire a 65% controlling interest in MRO Holdings, aiming to expand its aviation aftermarket platform and accelerate growth. The acquisition is expected to enhance scale, margins, and long-term growth prospects, with continued confidence in strong performance for the full fiscal year 2027.

AAR Corp.'s first quarter fiscal year 2027 results provide context for industrial sector activity. For readers following Industrials, here is Pluang's market snapshot as of Sep 29, 2026 03:41 WIB: out of 93 priced US Industrials stocks, 25 rose and 67 fell. Notable movers include JBLU at USD 4.23 with a -3.86% change and 44 days typical hold time, BAH at USD 70.24 with a -3.71% change and 80 days hold time, and PL at USD 16.79 with a -3.67% change and a 3-day hold time. All three had 0% Sell and 100% Buy order activity on Pluang.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
2 hours ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
2 hours ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
3 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
3 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App